Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.
about
Basophil Reactivity as Biomarker in Immediate Drug Hypersensitivity Reactions-Potential and LimitationsBioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In VitroStructural basis for quinine-dependent antibody binding to platelet integrin αIIbβ3.Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicitySuppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization modelThe pharmacogenomics of HIV therapy.Pathogenesis of drug-induced exanthems.Delayed drug hypersensitivity: models of T-cell stimulationNoncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactionsRole of bioactivation in drug-induced hypersensitivity reactions.Toxicity as a result of immunostimulation by biologics.Delayed drug hypersensitivity reactions - new concepts.Mechanisms of drug-induced allergy.Immune mediation of hypersensitivity adverse drug reactions: implications for therapy.In vitro tests of T cell-mediated drug hypersensitivity.Educational case series: Mechanisms of drug allergy.Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review.Identification & Characterization of lactobacillus salavarius bacteriocins and its relevance in cancer therapeutics.Drug hypersensitivity reactions in patients with HIV disease.The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors.Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53Isoniazid-induced liver injury and immune response in mice.Peptide binding specificities of HLA-B*5701 and B*5801.Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity.Personalized medicine for HLA-associated drug-hypersensitivity reactionsMechanisms of Adverse Drug ReactionsDrug metabolism and drug toxicity
P2860
Q26744628-EEC30D79-7483-4142-80D6-23F3A750D624Q28552429-0E5BC97D-8CDB-4EA6-929B-C34FB44759FCQ33425235-9ECFECB6-CC58-416D-BB7D-5D11E2474A04Q34200596-522286FD-F026-4195-A9F2-3290D004D5F9Q34394199-2E9E3280-A523-4864-95DF-207C522877BCQ34574033-BDF22E20-389E-40A5-A1B7-CBEFC7CB359DQ34881170-9C33068E-71CC-4834-91B9-E5424B217220Q34976476-261F79B6-07FF-4512-9BD6-5265034A7A73Q36439171-D14F238F-0181-40DA-BEA1-637B5E143C95Q36439187-98FC7FF3-F82F-438F-9E32-7F5A2FDCA08AQ36788414-7015ED4E-629E-4B5D-95A5-F8AF673ED011Q36854118-F079FEA0-A2A6-4923-B094-FE21C7E3DF68Q37148433-BDDF42DB-15E2-40A2-A5DF-41CBD5483E19Q37510953-777D137A-7F33-46C7-A7A9-CAABCC5AF0A0Q37754599-3BE95C1B-BF01-46ED-9C98-F67FB3BC3FCFQ37885432-CE47B925-DBA9-48B0-A2C4-3AED3CDCF739Q38268600-15EFC19C-4D05-49CD-A870-0C2DCD13232AQ39580304-D5C2E710-C148-4A9D-8D71-26592059B864Q40218681-5AF7BE50-AD7E-4C6F-9E26-16743FECC7E8Q40619738-1C8589A9-3DD0-4C9B-B04C-A4D04F858424Q41573303-79D28FE7-9FD7-4267-8647-F294F0FEAA4FQ46963836-DFBFE38E-497A-4BCE-9169-FDFBF5BB54C6Q51317293-6ADD88E5-4EEB-4E1A-B093-0AC066FE1EA7Q53266106-DE454454-C8B2-4429-999D-17E7AFAA9088Q57223243-D737E9E3-3474-4058-9E6F-41AB5950C3A5Q57302639-58B6CE3C-C079-4F1B-95B5-D8F990EB8B1BQ57302790-DA8905CE-F377-4EFC-8A42-3A499C9C4BAB
P2860
Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunological principles of ad ...... es elicited by drug treatment.
@ast
Immunological principles of ad ...... es elicited by drug treatment.
@en
Immunological principles of ad ...... es elicited by drug treatment.
@nl
type
label
Immunological principles of ad ...... es elicited by drug treatment.
@ast
Immunological principles of ad ...... es elicited by drug treatment.
@en
Immunological principles of ad ...... es elicited by drug treatment.
@nl
prefLabel
Immunological principles of ad ...... es elicited by drug treatment.
@ast
Immunological principles of ad ...... es elicited by drug treatment.
@en
Immunological principles of ad ...... es elicited by drug treatment.
@nl
P2093
P1433
P1476
Immunological principles of ad ...... es elicited by drug treatment.
@en
P2093
D J Naisbitt
S F Gordon
P304
P356
10.2165/00002018-200023060-00002
P577
2000-12-01T00:00:00Z
P6179
1049653919